Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail
-

NEW ANIMAL DRUG APPROVALS - November/December 2001

FDA Veterinarian Newsletter November/December 2001 Volume XVI, No VI

CompanyGeneric and (Brand) NamesIndicationsRoutes/Remarks
Bayer Corp., Agriculture Division, Animal Health
(NADA 141-188)		Ponazuril (MarquisTM) RxHorses. For the treatment of equine protozoal myeloencephalitis.ORAL: The NADA provides for veterinary prescription use of ponazuril paste for the treatment of equine protozoal myeloencephalitis caused by Sarcocystis neurona. Use daily for 28 days. Not for use in horses intended for food.
Federal Register 08/21/01
Alpharma, Inc.
(NADA 141-179)		Lasalocid (Avatec®),
Bacitracin Methylene Disalicylate (BMD®)		Turkeys. For the prevention of coccidiosis, for increased rate of weight gain, and for improved feed efficiency.MEDICATED FEED: The NADA provides for use of approved single-ingredient lasalocid and bacitracin methylene disalicylate Type A medicated articles to make two-way combination drug Type C medicated feeds. The medicated feeds are used for prevention of coccidiosis caused by Eimeria meleagrimitis, E. gallopavonis, E. adenoeides.
Federal Register 09/05/01
-
-